Ophthalmic devices include vision care products and surgery devices for the diagnosis and treatment of eye diseases. Risk of eye related diseases or retinal disorders such as vision defects (refraction), cataracts, and glaucoma, increase with age and can be chronic in several cases. Increasing prevalence of eye related disorders such as cataract, glaucoma, and blindness is expected to drive growth of the ophthalmic devices market. For instance, according to The International Agency for the Prevention of Blindness (IAPB), in 2015; 253 million people were blind or vision impaired, worldwide.
Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/686
Moreover, increasing prevalence of eye disorders in geriatric population and changing food habits leading to nutritional deficits in younger population are resulting in increasing adoption of ophthalmic devices. For instance, according to the International Journal of Advanced Medical and Health Research 2015, cataract is a major cause of blindness, affecting 17-18 million people worldwide, accounting for 39% of such cases.
Technological advancements in ophthalmic devices and increasing initiatives by government and healthcare regulatory bodies to ensure establishment of sophisticated healthcare infrastructure and better eye safety and vision care is are expected to propel growth of the ophthalmic devices market. American Academy of Ophthalmology: a global association of eye physicians and surgeons, each month; engaged in raising awareness regarding eye health among the global population.
Governments in emerging economies are focused on establishing sophisticated healthcare infrastructure and eye care centers. This is owing to increasing demand for treatment related to eye disorders such as cataract, glaucoma, and macular degeneration. This is turn is expected to boost growth of the global ophthalmic devices market.
For instance, Directorate General of Health Services: Government of India launched a National Program for Control of Blindness and Visual Impairment (NPCB&VI) in 1976 with the goal of reducing the prevalence of blindness to 0.3% by 2020. A current survey in progress (2015-18) shows projected rate of prevalence of blindness is 0.45%. Government of India is focused on lowering this rate to 0.3% by 2020.
Increasing Incidence of Eye Disorders is expected to Augment the Market Growth
Increasing prevalence of eye disorders such as glaucoma, diabetic retinopathy, macular degeneration, and cataract is expected to drive growth of the ophthalmic devices market. For instance, according to the International Journal of Advanced Medical and Health Research: 2015, cataract is a major cause of blindness and affects 17-18 million people worldwide, accounting for 39% of such cases, among overall blindness cases. Following cataract, glaucoma is the second major cause of blindness worldwide.
Increasing Adoption of Refurbished Ophthalmic Devices is Expected to Hinder the Market Growth
Among ophthalmic devices segment, ophthalmic imaging devices in the refurbished form witness increasing demand due to low production & material cost. However, this adversely affects the sales of manufacturer build or OEM build ophthalmic devices.
For instance, according to the Refurbishment of Medical Equipment Report on promising Key Enabling Technologies (KETs)-based product, published by European Commission in August 2017, refurbished diagnostic imaging equipment accounted for 75.5% of the global demand for refurbished medical devices, in 2015.
Buy Now This Report: https://www.coherentmarketinsights.com/insight/buy-now/686
Key companies covered as a part of this study include, Carl Zeiss Meditec Group, Escalon Medical Corp., Haag-Streit AG, Heidelberg Engineering GmbH, Heine Optotechnik GmbH & Co. KG, Essilor International S.A., NIDEK CO., LTD., Quantel Medical SAS, Luneau Technology Group, and Topcon Corporation.